Jenoptik AG · XETR:JEN
Jenoptik — 9M 2026 Earnings Presentation
14 slides from Jenoptik's earnings presentation, Nov 10, 2026
Slide 1: JENOPTIK AG – Nine months 2026
JENOPTIK AG – Nine months 2026 Dr. Dominic Dorfner, CEO I Dr. Prisca Havranek-Kosicek, CFO I November 10, 2026 © Copyright Jenoptik. All rights reserved.
Slide 2: Disclaimer
Disclaimer This presentation can contain forward-looking statements that are based on current expectations and certain assumptions of the management of the Jenoptik Group. A variety of known and unknown risks, uncertainties and other factors can cause the actual results, the financial situation, the
Slide 3: First nine months 2026
First nine months 2026
Slide 4: Order intake and profitability reached record levels
Order intake and profitability reached record levels Business development: Semiconductor & − Continuing very strong demand in the OEM businesses, both in semiconductor equipment Advanced Manufacturing and biophotonics − Strong demand is now also reflected in revenue performance − EBITDA margin and f
Slide 5: Order intake remained at very high level
Order intake remained at very high level Order intake in MEUR 41.4% In million euros 9M/2026 9M/2025 Change in % 1200 1,099.2 Semiconductor & Advanced Manufacturing 562.9 297.6 89.1 375.8 Biophotonics 237.1 213.2 11.2 900 Q3 Metrology & Production Solutions 159.5 158.8 0.5 777.3 Smart Mobility Solut
Slide 6: Semiconductor equipment area was main driver of revenue growth
Semiconductor equipment area was main driver of revenue growth Revenue in MEUR 1000 In million euros 9M/2026 9M/2025 Change in % 6.7% Semiconductor & Advanced Manufacturing 367.4 314.9 16.7 803.8 Biophotonics 180.1 182.1 –1.1 753.2 750 300.6 Metrology & Production Solutions 130.9 139.0 –5.8 254.8 Sm
Slide 7: EBITDA growth mainly supported by product mix effects; EBITDA margin increased to 22.2%
EBITDA growth mainly supported by product mix effects; EBITDA margin increased to 22.2% compared to prior-year level of 17.5% EBITDA in MEUR 200 EBITDA in million euros EBITDA in % 35.2% 178.2 9M/2026 9M/2025 9M/2026 9M/2025 79.3 Semiconductor & Advanced 160 Manufacturing 126.6 78.2 33.9 24.1 131.8
Slide 8: EPS up by 60% despite automotive-related impairment
EPS up by 60% despite automotive-related impairment; earnings figures significantly improved year-on-year In million euros 9M/2026 9M/2025 Change in % − Gross margin improved in particular due to higher Revenue 803.8 753.2 6.7 contribution by Semiconductor & Advanced Gross margin 37.2% 31.9% Manufac
Slide 9: Free cash flow improved in spite of increase in working capital
Free cash flow improved in spite of increase in working capital; financial position remains robust In million euros 9M/2026 9M/2025 Change in % Cash flows from operating − Cash flows from operating activities impacted by 147.1 139.7 5.3 activities before income taxes higher earnings before tax and d
Slide 10: Outlook
Outlook
Slide 11: Guidance for EBITDA margin for 2026 now at approximately 22 percent
Guidance for EBITDA margin for 2026 now at approximately 22 percent Semiconductor & Advanced Manufacturing Targets 2026 − Revenue growth anticipated to be unchanged between 5 and 9 percent (2025: 1,046.0 million euros) Biophotonics − EBITDA margin of approx. 22 percent (before between 20.0 and 21.0
Slide 12: Appendix
Appendix
Slide 13: New organizational and reporting structure
New organizational and reporting structure Semiconductor & Metrology & Smart Mobility Advanced Biophotonics Production Solutions Manufacturing Solutions − Optical and micro- − Optical components for − Systems and service for − Camera systems and optical components for life science & medical inspecti
Slide 14: Dates and contact
Dates and contact 10.11.2026 Results of first nine months 2026 17.11.2026 BNP Paribas Midcap Conference, Paris (CEO/CFO/IR) 18.11.2026 Morgan Stanley European Technology Media Telecom Conference, Barcelona (CFO/IR) 24.11.2026 Eigenkapitalforum, Frankfurt/Main (IR) 03.12.2026 Jenoptik Capital Markets